Rocket Pharmaceuticals, Inc. (RCKT) stock
RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11+0.00 (0.00%)
Close on Nov 18, 2026Market cap $231.62MP/E –Yield –
Rocket Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Rocket Pharmaceuticals's enterprise value was -$12.04M on Nov 11, 2026, against $147.27M a year earlier. Over the last 5 years it ranged from -$56.65M to $2.26B, with a median of $742.89M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$12.04M | -107.7% |
| 2025 | Dec 31, 2025 | $157.01M | -82.7% |
| 2024 | Dec 31, 2024 | $909.64M | -59.8% |
| 2023 | Dec 29, 2023 | $2.26B | +121.8% |
| 2022 | Dec 30, 2022 | $1.02B | +3.6% |
| 2021 | Dec 31, 2021 | $985.28M | -64.8% |
| 2020 | Dec 31, 2020 | $2.80B | +241.1% |
| 2019 | Dec 31, 2019 | $820.42M | +90.4% |
| 2018 | Dec 31, 2018 | $430.88M | – |
| 2017 | Dec 29, 2017 | -$32.07M | -220.2% |
| 2016 | Dec 30, 2016 | $26.69M | -85.2% |
| 2015 | Dec 31, 2015 | $180.86M | – |
See a number that looks wrong?